Key result
Laparoscopic sleeve gastrectomy linked to a ~22% lower NLR and improved glucose and lipid profiles.
Why the study?
Chronic inflammation underlies many obesity-related comorbidities, and the study aimed to retrospectively evaluate changes in obesity-related biochemical and hematological parameters after laparoscopic sleeve gastrectomy.
Does laparoscopic sleeve gastrectomy improve inflammatory, glucose, and lipid profiles in obese patients?
Observational (n=149)
No
Does laparoscopic sleeve gastrectomy improve inflammatory, glucose, and lipid profiles in obese patients?
Mean Difference: 0.56 (95% CI 0.21–0.91)
Absolute Event Rate: 2.03% vs 2.59%
p-value: p=0.013
Laparoscopic sleeve gastrectomy improves inflammatory markers, glucose, and lipid profiles at 6 months, correlating with BMI reduction.
Sleeve gastrectomy was associated with reduced inflammation and metabolic gains at 6 months; leaves open causality and durability in obese patients.
Obesity, with its many associated diseases, is the fastest growing public health problem worldwide. Obesity related chronic inflammation is the main pathophysiological basis in many obesty related comorbidities. In obesity, hypertrophic growth of adipose tissue is associated with the stimulation of the secretion of inflammatory mediators such as tumor necrosis factor-alpha (TNF-a) and interleukin-6 (IL-6) (2, 3). Continued release of inflammatory mediators leads to chronic inflammation.Inflammatory markers such as neutrophil-lymphocyte ratio (NLR) and platelet / lymphocyte ratio (PLR), which are used as diagnostic and prognostic factors in infectious diseases, have been shown to play an important role in the prognostic evaluations in many diseases. The aim of this study is to retrospectively investigate the changes in these obesty related biochemical and hematological parameters 6 months after laparoscopic sleeve gastrectomy (LSG). In addition we also retrospectively reviewed the findings of abdominal ultrasonography (US) examinations in all patients and computed tomography (CT) findings in patients who had been performed, in terms of postoperative complications. In our study, the improvements in inflamatory markers in addition to glucose and lipid profiles have been showed with a possitive correlation parallel to the change in BMI.
No takes yet. Share an insight, caveat, or question.
Akyol et al. (2021) conducted an observational in Obesity (n=149). Laparoscopic sleeve gastrectomy vs. Preoperative baseline was evaluated on Neutrophil-lymphocyte ratio (NLR) (MD 0.56, 95% CI 0.21-0.91, p=0.013). Laparoscopic sleeve gastrectomy significantly reduced the neutrophil-lymphocyte ratio from 2.59 to 2.03 (p=0.013) and improved glucose and lipid profiles at 6 months post-surgery.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: